Centre for Evolution and Cancer
... surprised therefore that it has great relevance to cancer. The idea that cancer is fundamentally a process of somatic cell evolution was first advocated in the 1970s. Since then, the concept has been validated and greatly elaborated, highlighting the striking parallels with Darwinian evolution by na ...
... surprised therefore that it has great relevance to cancer. The idea that cancer is fundamentally a process of somatic cell evolution was first advocated in the 1970s. Since then, the concept has been validated and greatly elaborated, highlighting the striking parallels with Darwinian evolution by na ...
miR34a is an intracellular and exosomal predictive
... INTRODUCTION Increased release of prostate-specific antigen (PSA) into circulation has been associated with the onset of prostate cancer. For this reason, its detection in serum has become a universal tool in screening for the disease; particularly in combination with digital rectal examination (DRE ...
... INTRODUCTION Increased release of prostate-specific antigen (PSA) into circulation has been associated with the onset of prostate cancer. For this reason, its detection in serum has become a universal tool in screening for the disease; particularly in combination with digital rectal examination (DRE ...
Brachytherapy
... Individual with low-risk of recurrence (tumor stage T1-T2a, low Gleason score ([GS] less than or equal to 6), serum prostate specific antigen (PSA) level below 10ng/mL and greater than or equal to 10 year expected survival Treatment will involve permanent low dose rate (LDR) brachytherapy as monothe ...
... Individual with low-risk of recurrence (tumor stage T1-T2a, low Gleason score ([GS] less than or equal to 6), serum prostate specific antigen (PSA) level below 10ng/mL and greater than or equal to 10 year expected survival Treatment will involve permanent low dose rate (LDR) brachytherapy as monothe ...
Dr. Yul D - Bangladesh Society of Medicine
... Case finding should be continuous (not just a "once and for all" project) Accepted treatment for patients with recognized disease Facilities for diagnosis and treatment available Agreed policy concerning whom to treat as patients Costs of case finding (including diagnosis and treatment of patients d ...
... Case finding should be continuous (not just a "once and for all" project) Accepted treatment for patients with recognized disease Facilities for diagnosis and treatment available Agreed policy concerning whom to treat as patients Costs of case finding (including diagnosis and treatment of patients d ...
Brachytherapy
... Individual with low-risk of recurrence (tumor stage T1-T2a, low Gleason score ([GS] less than or equal to 6), serum prostate specific antigen (PSA) level below 10ng/mL and greater than or equal to 10 year expected survival Treatment will involve permanent low dose rate (LDR) brachytherapy as monothe ...
... Individual with low-risk of recurrence (tumor stage T1-T2a, low Gleason score ([GS] less than or equal to 6), serum prostate specific antigen (PSA) level below 10ng/mL and greater than or equal to 10 year expected survival Treatment will involve permanent low dose rate (LDR) brachytherapy as monothe ...
Review of Animal Models of Prostate Cancer Bone Metastasis
... metastatic potential, and no survival difference has been found for the different histologic subtypes [31]. At the time of necropsy, it has been reported that up to 80% of dogs with a primary prostate carcinoma will have gross metastases with skeletal metastases (predominantly in the axial skeleton) ...
... metastatic potential, and no survival difference has been found for the different histologic subtypes [31]. At the time of necropsy, it has been reported that up to 80% of dogs with a primary prostate carcinoma will have gross metastases with skeletal metastases (predominantly in the axial skeleton) ...
Prostate Cancer Awareness and Quality Improvement Programme
... The Prostate Cancer Awareness and Quality Improvement Programme (AQIP) outlines the current issues for the early detection and treatment of prostate cancer in New Zealand. The AQIP also provides solutions to these issues and identifies the next steps for the Ministry of Health (the Ministry) and the ...
... The Prostate Cancer Awareness and Quality Improvement Programme (AQIP) outlines the current issues for the early detection and treatment of prostate cancer in New Zealand. The AQIP also provides solutions to these issues and identifies the next steps for the Ministry of Health (the Ministry) and the ...
Teenage Cancer Trust response to Cancer Taskforce consultation
... around 2,000 in England alone1. Approximately the same number will continue to receive care or will relapse which makes up for a very distinct group of cancer patients. Cancer kills more young people in the UK than any other disease and survival varies greatly between cancer types, from 96% 5 year s ...
... around 2,000 in England alone1. Approximately the same number will continue to receive care or will relapse which makes up for a very distinct group of cancer patients. Cancer kills more young people in the UK than any other disease and survival varies greatly between cancer types, from 96% 5 year s ...
Association of Directors of Anatomic and Surgical Pathology
... For all types of specimens (needle, TURP, enucleation, radical prostatectomy), when there is a minor secondary component (<5% of tumor) and where the secondary component is of higher grade, the latter should be reported. For example, a case showing more than 95% Gleason pattern 3 and less than 5% Gl ...
... For all types of specimens (needle, TURP, enucleation, radical prostatectomy), when there is a minor secondary component (<5% of tumor) and where the secondary component is of higher grade, the latter should be reported. For example, a case showing more than 95% Gleason pattern 3 and less than 5% Gl ...
Lung cancer facts and figures - Roy Castle Lung Cancer Foundation
... The more you smoke, the more likely you are to get lung cancer. But the length of time you have been a smoker is most important. As soon as you stop smoking, your risk of lung cancer starts to go down. However long you have been smoking, it’s never too late to give up. Exposure to secondhand smoke ( ...
... The more you smoke, the more likely you are to get lung cancer. But the length of time you have been a smoker is most important. As soon as you stop smoking, your risk of lung cancer starts to go down. However long you have been smoking, it’s never too late to give up. Exposure to secondhand smoke ( ...
Longitudinal Cytokine Expression during IMRT for Prostate Cancer
... cancer and receiving either definitive IMRT of 78 Gy (n = 22) or postoperative (adjuvant or salvage) IMRT of 66 to 70 Gy (n = 20; 2 Gy per fraction) were enrolled in this pilot study. None of the patients received hormone therapy at any point during this study. Patients were recruited from December ...
... cancer and receiving either definitive IMRT of 78 Gy (n = 22) or postoperative (adjuvant or salvage) IMRT of 66 to 70 Gy (n = 20; 2 Gy per fraction) were enrolled in this pilot study. None of the patients received hormone therapy at any point during this study. Patients were recruited from December ...
Company Background - People Living with Cancer
... network as well as hosting ongoing national support groups in various communities. However, the evidence collated over the years is clear - too many South Africans are excluded from basic services, support and information due to the remoteness of our country. The Pocket Cancer Support initiative was ...
... network as well as hosting ongoing national support groups in various communities. However, the evidence collated over the years is clear - too many South Africans are excluded from basic services, support and information due to the remoteness of our country. The Pocket Cancer Support initiative was ...
Risk of second cancer following radiotherapy for prostate cancer: a
... and bladder cancer) a complex picture emerges: At first glance, the rate of SC is increased after RT only – however no such increase is detectable in patients receiving both RPE and RT with the lowest absolute rate of rectal cancer being visible in patients having had both treatments. Based on pure ...
... and bladder cancer) a complex picture emerges: At first glance, the rate of SC is increased after RT only – however no such increase is detectable in patients receiving both RPE and RT with the lowest absolute rate of rectal cancer being visible in patients having had both treatments. Based on pure ...
Overdiagnosis during lung cancer screening
... shows how nuanced the concept of overdiagnosis is. Importantly, it presents the findings in a way that moves us towards clinical applicability. But there are leaps: (A) it is based on histology, which we can’t fully define until after resection and (B) the correlation between radiographic appearance a ...
... shows how nuanced the concept of overdiagnosis is. Importantly, it presents the findings in a way that moves us towards clinical applicability. But there are leaps: (A) it is based on histology, which we can’t fully define until after resection and (B) the correlation between radiographic appearance a ...
Current Status of Cancer Burden: Global and Indian Scenario
... Mumbai, India, and Tata Memorial Hospital, Mumbai, India, with an article on ovarian cancer, a heterogenous disease, and fourth most common cancer in India. The authors review and detail the cancer stages, and indicate the possible use of biomarkers including CA-125, useful in differential diagnosis ...
... Mumbai, India, and Tata Memorial Hospital, Mumbai, India, with an article on ovarian cancer, a heterogenous disease, and fourth most common cancer in India. The authors review and detail the cancer stages, and indicate the possible use of biomarkers including CA-125, useful in differential diagnosis ...
Nigeria. Nigerian Quarterly Journal of Hospital Medicine 19, 114-118
... important basis for determining the priorities for cancer control in any population group. There are marked differences in distribution of cancers in different regions of the world (Pisani, 1994). Environmental and socio-cultural factors such as active and passive tobacco smoking, use of non-smoking ...
... important basis for determining the priorities for cancer control in any population group. There are marked differences in distribution of cancers in different regions of the world (Pisani, 1994). Environmental and socio-cultural factors such as active and passive tobacco smoking, use of non-smoking ...
The National Academy of Clinical Biochemistry
... the UK National External Quality Assessment Service (UK NEQAS) for PSA, for example, confirm that mean geometric coefficients of variation (which reflect scatter) decreased from 21.9% in 1995, before the 1st IRR was introduced, to 9.5% in 2004 (19). The recently established IRR for isoforms of hCG ( ...
... the UK National External Quality Assessment Service (UK NEQAS) for PSA, for example, confirm that mean geometric coefficients of variation (which reflect scatter) decreased from 21.9% in 1995, before the 1st IRR was introduced, to 9.5% in 2004 (19). The recently established IRR for isoforms of hCG ( ...
Nerve–Cancer Cell Cross-talk: A Novel Promoter of Tumor
... and therefore it is still to be determined whether a similar nervedependent tumor growth takes place. In breast cancer, it has been shown that the sympathetic nervous system can induce a metastatic switch (29), but a possible relationship with nerve fiber infiltration in breast tumors has yet to be es ...
... and therefore it is still to be determined whether a similar nervedependent tumor growth takes place. In breast cancer, it has been shown that the sympathetic nervous system can induce a metastatic switch (29), but a possible relationship with nerve fiber infiltration in breast tumors has yet to be es ...
Treatment of Prostate Cancer - National Imaging Associates
... accompanying graphics regarding the fiveyear survival rate for prostate cancer overall and by stage at diagnosis, the probability of developing prostate cancer, and more. In addition, we have expanded this feature to include “Stakeholder Insights” and “Claims Benchmarks.” We hope you find these new ...
... accompanying graphics regarding the fiveyear survival rate for prostate cancer overall and by stage at diagnosis, the probability of developing prostate cancer, and more. In addition, we have expanded this feature to include “Stakeholder Insights” and “Claims Benchmarks.” We hope you find these new ...
Cancer diagnosis in primary care
... cancer.51 Like the biomarkers, much more research is required before this can be used in primary care. Much simpler than these methods are scoring systems for use in those with a low-risk-but-not-no-risk symptom. Two have been advocated: the CAPER score and the SELVA score.18 52 Both have similar pr ...
... cancer.51 Like the biomarkers, much more research is required before this can be used in primary care. Much simpler than these methods are scoring systems for use in those with a low-risk-but-not-no-risk symptom. Two have been advocated: the CAPER score and the SELVA score.18 52 Both have similar pr ...
Five inequalities, five solutions.
... 58% of prostate cancer patients were unable to have an erection 1-5 years after treatment, with a further 11% having significant difficulty in having or maintaining an erection, 13% having difficulty controlling their bowels and 39% having some degree of urinary leakage. The presence of urinary leak ...
... 58% of prostate cancer patients were unable to have an erection 1-5 years after treatment, with a further 11% having significant difficulty in having or maintaining an erection, 13% having difficulty controlling their bowels and 39% having some degree of urinary leakage. The presence of urinary leak ...